CVS Health Corporation
General ticker "CVS" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $105.3B (TTM average)
CVS Health Corporation follows the US Stock Market performance with the rate: 42.1%.
Estimated limits based on current volatility of 1.6%: low 89.70$, high 92.61$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-07-23, amount 0.67$ (Y2.90%)
- Total employees count: 300000 (0.0%) as of 2025
- Top business risk factors: Regulatory and compliance, Economic downturns and volatility, Public perception, Drug supply shortages, Healthcare cost prediction
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [70.84$, 107.65$]
- 2026-12-31 to 2027-12-31 estimated range: [79.79$, 119.46$]
Financial Metrics affecting the CVS estimates:
- Negative: with PPE of 11.7 at the end of fiscal year the price was high
- Positive: 8.77 < Operating cash flow per share per price, % of 10.60
- Positive: 0.59 < Industry operating profit margin (median), % of 1.57
- Positive: 0.56 < Operating profit margin, % of 2.58
- Positive: 25.20 < Shareholder equity ratio, % of 29.67 <= 34.41
- Negative: -0.37 < Inventory ratio change, % of -0.08
- Positive: Industry inventory ratio change (median), % of 0.22 <= 0.47
- Positive: -7.11 < Investing cash flow per share per price, % of -5.85
- Negative: 2.54 < Interest expense per share per price, % of 3.11
Short-term CVS quotes
Relationship graph
Long-term CVS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $357,776.00MM | $372,809.00MM | $402,067.00MM |
| Operating Expenses | $344,033.00MM | $364,293.00MM | $391,682.00MM |
| Operating Income | $13,743.00MM | $8,516.00MM | $10,385.00MM |
| Non-Operating Income | $-2,570.00MM | $-2,368.00MM | $-8,249.00MM |
| Interest Expense | $2,658.00MM | $2,958.00MM | $3,119.00MM |
| Income(Loss) | $11,173.00MM | $6,148.00MM | $2,136.00MM |
| Taxes | $2,805.00MM | $1,562.00MM | $408.00MM |
| Net Income(Loss)* | $8,344.00MM | $4,614.00MM | $1,768.00MM |
| Stockholders Equity | $76,461.00MM | $75,560.00MM | $75,214.00MM |
| Inventory | $18,025.00MM | $18,107.00MM | $19,246.00MM |
| Assets | $249,728.00MM | $253,215.00MM | $253,538.00MM |
| Operating Cash Flow | $13,426.00MM | $9,107.00MM | $10,639.00MM |
| Capital expenditure | $3,031.00MM | $2,781.00MM | $2,832.00MM |
| Investing Cash Flow | $-20,889.00MM | $-7,613.00MM | $-5,871.00MM |
| Financing Cash Flow | $2,683.00MM | $-1,135.00MM | $-4,940.00MM |
| Earnings Per Share** | $6.49 | $3.66 | $1.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.